A high ruminal protein degradation is especially undesirable in high producing dairy cows and beef cattle, since these animals have high requirements of protein and the amount of protein that is not degraded by ruminal microorganisms and therefore enters the small intestine (so-called UDP = undegraded protein) is crucial. In this study, Merino rams with ruminal fistulas were used (n = 4) to determine the effect of glucose treatment of soybean meal (SBM), full fat soybean (FFSB) and soybean seed (SBS) on the ruminal degradability of dry matter (DM) and crude protein (CP). All these feedstuffs were grinded, diluted with water and heated (2 h; 100 degrees C) either without or with supplementation of 2 or 3% glucose (20 or 30 g glucose per kg dry feed). For the determination of the ruminal degradability nylon bag technique was used (incubation times: 2-48 h). In general ruminal degradability of protein in all three soy products was reduced by glucose treatment. In FFSB CP disappearance started to decrease after 8 h of incubation, whereas in SBM (+ 3% glucose) and SBS (+ 2 or 3% glucose) reduction of CP disappearance were time-independent. Further, effective degradability (Pe) of DM and CP of all feedstuffs were significantly reduced by glucose treatment, with the reduction being more pronounced when the glucose level was increased. When adding 3% of glucose, the Pe for CP was reduced by 6 (FFSB), 16 (SBM) and 18% (SBS), respectively. Explanation for the observed effects of a glucose supplementation (incl. water and heat treatment) is the reductive activity of glucose within these conditions.
Download full-text PDF |
Source |
---|
Drugs Aging
January 2025
Program for the Care and Study of the Aging Heart, Department of Medicine, Weill Cornell Medicine, 420 East 70th St, New York, NY, LH-36510063, USA.
There are several pharmacologic agents that have been touted as guideline-directed medical therapy for heart failure with preserved ejection fraction (HFpEF). However, it is important to recognize that older adults with HFpEF also contend with an increased risk for adverse effects from medications due to age-related changes in pharmacokinetics and pharmacodynamics of medications, as well as the concurrence of geriatric conditions such as polypharmacy and frailty. With this review, we discuss the underlying evidence for the benefits of various treatments in HFpEF and incorporate key considerations for older adults, a subpopulation that may be at higher risk for adverse drug events.
View Article and Find Full Text PDFCurr Cardiol Rep
January 2025
Pediatric Advanced Heart Failure and Heart Transplant Program, University of Mississippi Medical Center, 2500 N State Street, Jackson, MS, USA.
Purpose Of Review: Traditionally viewed as a passive player in circulation, the right ventricle (RV) has become a pivotal force in hemodynamics. RV failure (RVF) is a recognized complication of primary cardiac and pulmonary vascular disorders and is associated with a poor prognosis. Unlike treatments for left ventricular failure (LVF), strategies such as adrenoceptor signaling inhibition and renin-angiotensin system modulation have shown limited success in RVF.
View Article and Find Full Text PDFPlant Foods Hum Nutr
January 2025
College of Biology and Food Engineering, Chongqing Three Gorges University, Chongqing, 404100, China.
Insulin resistance was considered to be the most important clinical phenotype of type 2 diabetes (T2DM). Almond is a widely-consumed nut and long-term intake was beneficial to alleviating insulin resistance in patients with T2DM. Hence, screening of anti-diabetic peptides from almond proteins was feasible based on the effectiveness of peptides in the treatment of T2DM.
View Article and Find Full Text PDFAm J Physiol Heart Circ Physiol
January 2025
Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Department of Cardiology, Amsterdam, The Netherlands.
The acute response to therapeutic afterload reduction differs between heart failure with preserved (HFpEF) versus reduced ejection fraction (HFrEF), with larger left ventricular (LV) stroke work augmentation in HFrEF compared to HFpEF. This may (partially) explain the neutral effect of HFrEF-medication in HFpEF. It is unclear whether such differences in hemodynamic response persist and/or differentially trigger reverse remodeling in case of long-term afterload reduction.
View Article and Find Full Text PDFZhongguo Dang Dai Er Ke Za Zhi
January 2025
Department of Endocrine, Genetics and Metabolism, Children's Hospital Affiliated to Xi'an Jiaotong University, Xi'an 710003, China.
Maturity-onset diabetes of the young (MODY) is a special type of diabetes characterized by clinical features including early onset of diabetes (before 30 years of age), autosomal dominant inheritance, impaired glucose-induced insulin secretion, and hyperglycemia. So far, 14 types of MODY have been reported, accounting for about 1%-5% of the patients with diabetes. MODY often presents with an insidious onset, and although 14 subtypes have been identified for MODY, it is frequently misdiagnosed as type 1 or type 2 diabetes due to overlapping clinical features and high costs and limitations of genetic testing.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!